Meridian Bioscience (VIVO) Short Interest Ratio & Short Volume → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free VIVO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Meridian Bioscience Short Interest DataCurrent Short Volume4,240,000 sharesPrevious Short Volume3,810,000 sharesChange Vs. Previous Month+11.29%Dollar Volume Sold Short$142.72 millionShort Interest Ratio / Days to Cover8.9Last Record DateJanuary 15, 2023Outstanding Shares44,010,000 sharesFloat Size43,160,000 sharesShort Percent of Float9.82%Today's Trading Volume0 sharesAverage Trading Volume973,737 sharesToday's Volume Vs. Average0% Short Selling Meridian Bioscience ? Sign up to receive the latest short interest report for Meridian Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIVO Short Interest Over TimeVIVO Days to Cover Over TimeVIVO Percentage of Float Shorted Over Time Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here Meridian Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20234,240,000 shares $142.72 million +11.3%9.8%8.9 $33.66 12/30/20223,810,000 shares $126.53 million +11.1%8.8%8.8 $33.21 12/15/20223,430,000 shares $113.40 million +80.5%8.0%8.2 $33.06 11/30/20221,900,000 shares $60.80 million -2.1%4.4%6.5 $32.00 11/15/20221,940,000 shares $61.75 million -4.4%4.5%6.2 $31.83 10/31/20222,030,000 shares $64.90 million -9.4%4.7%6.3 $31.97 Get the Latest News and Ratings for VIVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Meridian Bioscience and its competitors with MarketBeat's FREE daily newsletter. 10/15/20222,240,000 shares $71.70 million +0.5%5.2%6.1 $32.01 9/30/20222,230,000 shares $70.31 million -22.8%5.2%4.4 $31.53 9/15/20222,890,000 shares $92.80 million -4.3%6.7%3.7 $32.11 8/31/20223,020,000 shares $98.42 million -10.7%7.0%3.8 $32.59 8/15/20223,380,000 shares $111.24 million +0.6%7.9%4.3 $32.91 7/31/20223,360,000 shares $106.38 million +18.7%7.8%4.3 $31.66 7/15/20222,830,000 shares $91.98 million -4.1%6.6%3.8 $32.50 6/30/20222,950,000 shares $89.74 million +12.6%7.1%4.5 $30.42 6/15/20222,620,000 shares $71.03 million +4.8%6.3%6.9 $27.11 5/31/20222,500,000 shares $68.75 million +8.2%5.8%7.6 $27.50 5/15/20222,310,000 shares $56.99 million -1.3%5.4%6.9 $24.67 4/30/20222,340,000 shares $59.88 million -3.7%5.5%5.8 $25.59 4/15/20222,430,000 shares $67.89 million -8.7%5.7%5.1 $27.94 3/31/20222,660,000 shares $69.05 million +17.2%6.2%5.3 $25.96 3/15/20222,270,000 shares $56.73 million -2.6%5.3%4.6 $24.99 2/28/20222,330,000 shares $58.95 million -6.4%5.4%4.4 $25.30 2/15/20222,490,000 shares $64.17 million -11.1%5.8%4.4 $25.77 1/31/20222,800,000 shares $58.38 million +27.3%6.5%4.6 $20.85 1/15/20222,200,000 shares $45.80 million -3.1%5.1%4.5 $20.82 12/31/20212,270,000 shares $46.31 million -3.0%5.3%5.2 $20.40 12/15/20212,340,000 shares $41.93 million No Change5.5%5.5 $17.92 11/30/20212,340,000 shares $46.59 million -24.0%5.5%6.1 $19.91 11/15/20213,080,000 shares $62.09 million -1.0%7.2%9.2 $20.16 10/29/20213,110,000 shares $58.50 million +1.0%7.3%11.5 $18.81 10/15/20213,080,000 shares $56.21 million +0.7%7.2%10.2 $18.25 9/30/20213,060,000 shares $58.87 million -10.0%7.2%7.8 $19.24 9/15/20213,400,000 shares $66.64 million -4.2%7.9%8.3 $19.60 8/31/20213,550,000 shares $71.85 million -8.3%8.3%8.3 $20.24 8/13/20213,870,000 shares $77.48 million -14.6%9.0%7.5 $20.02 7/30/20214,530,000 shares $92.87 million -6.2%10.6%8.5 $20.50 7/15/20214,830,000 shares $84.67 million -1.4%11.3%8.5 $17.53 6/30/20214,900,000 shares $108.68 million +0.4%11.5%8.5 $22.18 6/15/20214,880,000 shares $100.53 million +6.1%11.4%7.9 $20.60 5/28/20214,600,000 shares $95.50 million +2.7%10.8%6.9 $20.76What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here VIVO Short Interest - Frequently Asked Questions What is Meridian Bioscience's current short interest? Short interest is the volume of Meridian Bioscience shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 4,240,000 shares of VIVO short. 9.82% of Meridian Bioscience's shares are currently sold short. Learn More on Meridian Bioscience's current short interest. What is a good short interest ratio for Meridian Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIVO shares currently have a short interest ratio of 9.0. Learn More on Meridian Bioscience's short interest ratio. What is a good short interest percentage for Meridian Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.82% of Meridian Bioscience's floating shares are currently sold short. Is Meridian Bioscience's short interest increasing or decreasing? Meridian Bioscience saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 4,240,000 shares, an increase of 11.3% from the previous total of 3,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Meridian Bioscience's float size? Meridian Bioscience currently has issued a total of 44,010,000 shares. Some of Meridian Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Meridian Bioscience currently has a public float of 43,160,000 shares. How does Meridian Bioscience's short interest compare to its competitors? 9.82% of Meridian Bioscience's shares are currently sold short. Here is how the short interest of companies compare to Meridian Bioscience: QuidelOrtho Co. (4.05%), Neogen Co. (8.15%), Myriad Genetics, Inc. (6.08%), Intellia Therapeutics, Inc. (15.13%), Celldex Therapeutics, Inc. (12.08%), Riot Platforms, Inc. (13.60%), Aspira Women's Health Inc. (2.52%), Lantheus Holdings, Inc. (6.95%), ADMA Biologics, Inc. (3.55%), Zai Lab Limited (4.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Meridian Bioscience stock? Short selling VIVO is an investing strategy that aims to generate trading profit from Meridian Bioscience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Meridian Bioscience? A short squeeze for Meridian Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIVO, which in turn drives the price of the stock up even further. How often is Meridian Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIVO, twice per month. The most recent reporting period available is January, 15 2023. More Short Interest Resources from MarketBeat Related Companies: QDEL Short Interest NEOG Short Interest MYGN Short Interest NTLA Short Interest CLDX Short Interest RIOT Short Interest AWH Short Interest LNTH Short Interest ADMA Short Interest ZLAB Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIVO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals